Skip to main content
Caplight Logo









Cell X Technologies

Cell X Technologies

Private
Cleveland, OhioHealthcare & Life Scienceshttps://cellxtechnologies.com/

Last Round

Seed

Aug 1, 2024

Total Funding Raised

$6.83M

Company Overview

Cell X Technologies is a biotechnology company that develops an automated cell processing platform combining robotics, imaging, and artificial intelligence to streamline cell and gene therapy manufacturing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Computer Vision, Smart Manufacturing, Workflow Automation

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Application

Keywords

cell therapy manufacturingautomated cell processingbioprocessing automationGMP compliancelab automationcell culture automationregenerative medicinecomputer visionbio-manufacturingbiotech roboticsgood manufacturing practiceGMPautologous cell therapyallogeneic cell therapydigital biologysmart lab

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cell X Technologies Comparables

Compare Cell X Technologies with similar companies based on industry and business-model similarity.

Cell X Technologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Celltrio
88%
Mytos
85%
Multiply Labs
85%

Cell X Technologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedAug 1, 2024
AcceleratorJun 29, 2023
GrantSep 12, 2019

Key People

Founding team and executive leadership

Brian C. Handerhan

Chief Executive Officer

Executive Team

Cell X Technologies Investors

Notable investors and investment history

Cell X Technologies investors
InvestorRounds
NIH RADxGrant
Innovation WorksAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors increased 252% MoM, reaching 1K.

  • Jun 2, 2024

    Grew 36% QoQ, from 11 to 15 employees.

Cell X Technologies Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cell X Technologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cell X Technologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersCleveland, Ohio
Employee Range14
Year Founded2017
Last FundingAug 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?